BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2022 10:48:04 AM | Browse: 280 | Download: 826
 |
Received |
|
2022-10-15 04:15 |
 |
Peer-Review Started |
|
2022-10-15 04:17 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-10-26 22:04 |
 |
Revised |
|
2022-10-28 03:27 |
 |
Second Decision |
|
2022-12-02 03:08 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-12-05 17:27 |
 |
Articles in Press |
|
2022-12-05 17:27 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-12-11 20:03 |
 |
Publish the Manuscript Online |
|
2022-12-19 10:48 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Legal |
Manuscript Type |
Letter to the Editor |
Article Title |
The potential role of the three-dimensional-bioprinting model in screening and developing drugs
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Chao-Lin Deng and Bin Wu |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Bin Wu, MD, PhD, Chief Doctor, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan Road, Wangfujing, Dongcheng District, Beijing 100730, China. wubin0279@hotmail.com |
Key Words |
Colorectal cancer; three-dimensional-bioprinting; Mucinous adenocarcinoma; Drug screening models |
Core Tip |
Chemotherapy is the main treatment option for inoperable colorectal cancer (CRC). We recently read an article about the anti-cancer effects of Diiminoquinone. We feel obliged to express our opinion on this article on drug screening models and the difference between pathologic subtypes in CRC and hope it could deepen understanding for the reader. |
Publish Date |
2022-12-19 10:48 |
Citation |
Deng CL, Wu B. The potential role of the three-dimensional-bioprinting model in screening and developing drugs. World J Gastroenterol 2022; 28(47): 6788-6790 |
URL |
https://www.wjgnet.com/1007-9327/full/v28/i47/6788.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v28.i47.6788 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345